Your browser doesn't support javascript.
loading
Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer risk.
Shu, Xiang; Bao, Jiandong; Wu, Lang; Long, Jirong; Shu, Xiao-Ou; Guo, Xingyi; Yang, Yaohua; Michailidou, Kyriaki; Bolla, Manjeet K; Wang, Qin; Dennis, Joe; Andrulis, Irene L; Castelao, Jose E; Dörk, Thilo; Gago-Dominguez, Manuela; García-Closas, Montserrat; Giles, Graham G; Lophatananon, Artitaya; Muir, Kenneth; Olsson, Håkan; Rennert, Gadi; Saloustros, Emmanouil; Scott, Rodney J; Southey, Melissa C; Pharoah, Paul D P; Milne, Roger L; Kraft, Peter; Simard, Jacques; Easton, Douglas F; Zheng, Wei.
Afiliação
  • Shu X; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Bao J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Wu L; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Long J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Guo X; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Yang Y; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Bolla MK; Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
  • Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Andrulis IL; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Castelao JE; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Dörk T; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Gago-Dominguez M; Oncology and Genetics Unit, Instituto de Investigacion Biomedica (IBI) Galicia Sur, Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
  • García-Closas M; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Giles GG; Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS, Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  • Lophatananon A; Moores Cancer Center, University of California San Diego, La Jolla, CA.
  • Muir K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.
  • Olsson H; Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.
  • Rennert G; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
  • Saloustros E; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, United Kingdom.
  • Scott RJ; Institute of Population Health, University of Manchester, Manchester, United Kingdom.
  • Southey MC; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, United Kingdom.
  • Pharoah PDP; Institute of Population Health, University of Manchester, Manchester, United Kingdom.
  • Milne RL; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
  • Kraft P; Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
  • Simard J; Hereditary Cancer Clinic, University Hospital of Heraklion, Heraklion, Greece.
  • Easton DF; Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, NSW, Australia.
  • Zheng W; Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia.
Int J Cancer ; 146(8): 2130-2138, 2020 04 15.
Article em En | MEDLINE | ID: mdl-31265136
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Proteínas de Neoplasias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Tunísia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Proteínas de Neoplasias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Tunísia País de publicação: Estados Unidos